SB
SynBiotic SE
SBX.DE · XETRA
0.96 € -0.93% (-0.01 €)
1M -7.62%
Market Cap 4.75M €
P/E Ratio -
Div. Yield -
ROE -
Valuation
99 /100
Cheap P/S 1.23x
P/B 0.30x
P/E N/A
Growth
0 /100
Declining Rev. growth 10.83%
Book val. growth 14.75%
EPS growth N/A
Profitability
15 /100
Weak Gross margin 39.01%
Net margin 275.31%
FCF margin 76.23%
Quality
2 /100
Poor ROIC 39.27%
ROA 30.44%
Asset turnover 0.11x
Debt
52 /100
Moderate Debt/Equity 0.23x
Current ratio 0.81x
Int. coverage -59.80x
Stability
26 /100
Unstable Beta 0.68x
Rev. volatility 55.98%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SBX.DE
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Daniel Kruse
Employees
79
Headquarters
Düsseldorf